Related references
Note: Only part of the references are listed.Cutting Edge: GPR35/CXCR8 Is the Receptor of the Mucosal Chemokine CXCL17
Jose L. Maravillas-Montero et al.
JOURNAL OF IMMUNOLOGY (2015)
Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis
Chloe Rancoule et al.
BIOCHIMIE (2014)
Hypoxia-inducible factor 1-induced G protein-coupled receptor 35 expression is an early marker of progressive cardiac remodelling
Veli-Pekka Ronkainen et al.
CARDIOVASCULAR RESEARCH (2014)
Diet, Metabolites, and Western-Lifestyle Inflammatory Diseases
Alison N. Thorburn et al.
IMMUNITY (2014)
Crucial Positively Charged Residues for Ligand Activation of the GPR35 Receptor
Pingwei Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Biased Agonism at G Protein-Coupled Receptors: The Promise and the Challenges-A Medicinal Chemistry Perspective
Jeremy Shonberg et al.
MEDICINAL RESEARCH REVIEWS (2014)
Turning on cGMP-dependent pathways to treat cardiac dysfunctions: boom, bust, and beyond
Robert Lukowski et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Suvorexant for the treatment of insomnia
Laura H. Jacobson et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2014)
The Antiallergic Mast Cell Stabilizers Lodoxamide and Bufrolin as the First High and Equipotent Agonists of Human and Rat GPR35
Amanda E. MacKenzie et al.
MOLECULAR PHARMACOLOGY (2014)
G Protein-Coupled Receptor Deorphanizations
Olivier Civelli et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 53, 2013 (2013)
Lysophosphatidic acid: Chemical signature of neuropathic pain
Hiroshi Ueda et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
Physiological roles of Rho and Rho effectors in mammals
Dean Thumkeo et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2013)
Genome-Wide Association Analysis in Primary Sclerosing Cholangitis and Ulcerative Colitis Identifies Risk Loci at GPR35 and TCF4
David Ellinghaus et al.
HEPATOLOGY (2013)
8-Benzamidochromen-4-one-2-carboxylic Acids: Potent and Selective Agonists for the Orphan G Protein-Coupled Receptor GPR35
Mario Funke et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
6-Bromo-8-(4-[3H]methoxybenzamido)-4-oxo-4H-chromene-2-carboxylic Acid: A Powerful Tool for Studying Orphan G Protein-Coupled Receptor GPR35
Dominik Thimm et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Molecular signatures of G-protein-coupled receptors
A. J. Venkatakrishnan et al.
NATURE (2013)
An inhibitor of the protein kinases TBK1 and IKK-ε improves obesity-related metabolic dysfunctions in mice
Shannon M. Reilly et al.
NATURE MEDICINE (2013)
GPR35 Activation Reduces Ca2+ Transients and Contributes to the Kynurenic Acid-Dependent Reduction of Synaptic Activity at CA3-CA1 Synapses
Rolando Berlinguer-Palmini et al.
PLOS ONE (2013)
The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction
Stephen J. Greene et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
High-Throughput Identification and Characterization of Novel, Species-selective GPR35 Agonists
Zaynab Neetoo-Isseljee et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Screening beta-Arrestin Recruitment for the Identification of Natural Ligands for Orphan G-Protein-Coupled Receptors
Craig Southern et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
Are GPCRs Still a Source of New Targets?
Stephen L. Garland
JOURNAL OF BIOMOLECULAR SCREENING (2013)
Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis
Mari Gotoh et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Thieno[3,2-b]thiophene-2-carboxylic acid derivatives as GPR35 agonists
Huayun Deng et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Invariant NKT cells increase drug-induced osteosarcoma cell death
S. Fallarini et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Lysophosphatidic acid in atherosclerotic diseases
Andreas Schober et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction
Loek van Heerebeek et al.
CIRCULATION (2012)
CXCL17 Is a Mucosal Chemokine Elevated in Idiopathic Pulmonary Fibrosis That Exhibits Broad Antimicrobial Activity
Amanda M. Burkhardt et al.
JOURNAL OF IMMUNOLOGY (2012)
Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery
Flavio Moroni et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Aspirin metabolites are GPR35 agonists
Huayun Deng et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2012)
GPR35 Is a Target of the Loop Diuretic Drugs Bumetanide and Furosemide
Yuhua Yang et al.
PHARMACOLOGY (2012)
Multiple tyrosine metabolites are GPR35 agonists
Huayun Deng et al.
SCIENTIFIC REPORTS (2012)
Antagonists of GPR35 Display High Species Ortholog Selectivity and Varying Modes of Action
Laura Jenkins et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Agonist activation of the G protein-coupled receptor GPR35 involves transmembrane domain III and is transduced via Gα13 and β-arrestin-2
Laura Jenkins et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
What makes a good drug target?
Isabella Gashaw et al.
DRUG DISCOVERY TODAY (2011)
Tyrphostin analogs are GPR35 agonists
Huayun Deng et al.
FEBS LETTERS (2011)
Discovery of 2-(4-Methylfuran-2(5H)-ylidene)malononitrile and Thieno[3,2-b]thiophene-2-carboxylic Acid Derivatives as G Protein-Coupled Receptor 35 (GPR35) Agonists
Huayun Deng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Trends in the exploitation of novel drug targets
Mathias Rask-Andersen et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast
Cristina Cosi et al.
NEUROPHARMACOLOGY (2011)
Orthologue selectivity and ligand bias: translating the pharmacology of GPR35
Graeme Milligan
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
GPR35 as a Novel Therapeutic Target
A. E. MacKenzie et al.
Frontiers in Endocrinology (2011)
GPR35 is a novel lysophosphatidic acid receptor
Saori Oka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Identification of genes related to heart failure using global gene expression profiling of human failing myocardium
Kyung-Duk Min et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13
Laura Jenkins et al.
BIOCHEMICAL JOURNAL (2010)
Mind Your Salts: When the Inactive Constituent Isn't
Richard R. Neubig
MOLECULAR PHARMACOLOGY (2010)
Targeting of the Orphan Receptor GPR35 by Pamoic Acid: A Potent Activator of Extracellular Signal-Regulated Kinase and β-Arrestin2 with Antinociceptive Activity
Pingwei Zhao et al.
MOLECULAR PHARMACOLOGY (2010)
Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling
Louis M. Luttrell et al.
PHARMACOLOGICAL REVIEWS (2010)
G-Protein-Coupled Receptor 35 Is a Target of the Asthma Drugs Cromolyn Disodium and Nedocromil Sodium
Yuhua Yang et al.
PHARMACOLOGY (2010)
High concentration of kynurenic acid in bile and pancreatic juice
Piotr Paluszkiewicz et al.
AMINO ACIDS (2009)
Regulation of RhoGEF proteins by G12/13-coupled receptors
Sandra Siehler
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Kynurenic Acid Triggers Firm Arrest of Leukocytes to Vascular Endothelium under Flow Conditions
Marita C. Barth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Common variants at five new loci associated with early-onset inflammatory bowel disease
Marcin Imielinski et al.
NATURE GENETICS (2009)
Myocardial protection against reperfusion injury: The cGMP pathway
David Garcia-Dorado et al.
THROMBOSIS AND HAEMOSTASIS (2009)
Micromolar concentration of kynurenic acid in rat small intestine
D. Kuc et al.
AMINO ACIDS (2008)
GPR35 is a functional receptor in rat dorsal root ganglion neurons
Hiroyuki Ohshiro et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Inhibition of N-type calcium channels by activation of GPR35, an orphan receptor, heterologously expressed in rat sympathetic neurons
Juan Guo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Zaprinast inhibits hydrogen peroxide-induced lysosomal destabilization and cell death in astrocytes
Jae-Hyuck Choi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35
Yasuhito Taniguchi et al.
FEBS LETTERS (2006)
Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35
Jinghong Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Lack of the nitric oxide-cyclic GMP-potassium channel pathway for the antinociceptive effect of intrathecal zaprinast in a rat formalin test
MH Yoon et al.
NEUROSCIENCE LETTERS (2005)
Target-based drug discovery: is something wrong?
F Sams-Dodd
DRUG DISCOVERY TODAY (2005)
Low-T3 syndrome - A strong prognostic predictor of death in patients with heart disease
G Iervasi et al.
CIRCULATION (2003)
Knockouts model the 100 best-selling drugs - Will they model the next 100?
BP Zambrowicz et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
The druggable genome
AL Hopkins et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Rapid down-regulation of thyroid hormones in acute myocardial infarction - Is it cardioprotective in patients with angina?
L Friberg et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Y Horikawa et al.
NATURE GENETICS (2000)
Share Paper
